Antibodies Create Killer Bonds in Myeloma

Marta Chesi; Rafael Fonseca

doi:10.1016/j.ccell.2017.02.011

Antibodies Create Killer Bonds in Myeloma

Marta Chesi, Rafael Fonseca

Hematology/Oncology

Research output: Contribution to journal › Short survey › peer-review

1 Scopus citations

Abstract

In this issue of Cancer Cell, Li et al. and Seckinger et al. describe promising results of two T-cell-dependent bi-specific antibodies for the treatment of multiple myeloma: one targets FcRH5 expressed on B cells, whereas the other targets the B cell maturation antigen expressed on plasma cells.

Original language	English (US)
Pages (from-to)	305-307
Number of pages	3
Journal	Cancer cell
Volume	31
Issue number	3
DOIs	https://doi.org/10.1016/j.ccell.2017.02.011
State	Published - Mar 13 2017

ASJC Scopus subject areas

Oncology
Cell Biology
Cancer Research

Access to Document

10.1016/j.ccell.2017.02.011

Cite this

@article{cdd9433495d9437294fbe52eea37e16a,

title = "Antibodies Create Killer Bonds in Myeloma",

abstract = "In this issue of Cancer Cell, Li et al. and Seckinger et al. describe promising results of two T-cell-dependent bi-specific antibodies for the treatment of multiple myeloma: one targets FcRH5 expressed on B cells, whereas the other targets the B cell maturation antigen expressed on plasma cells.",

author = "Marta Chesi and Rafael Fonseca",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Inc.",

year = "2017",

month = mar,

day = "13",

doi = "10.1016/j.ccell.2017.02.011",

language = "English (US)",

volume = "31",

pages = "305--307",

journal = "Cancer cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "3",

}

TY - JOUR

T1 - Antibodies Create Killer Bonds in Myeloma

AU - Chesi, Marta

AU - Fonseca, Rafael

PY - 2017/3/13

Y1 - 2017/3/13

N2 - In this issue of Cancer Cell, Li et al. and Seckinger et al. describe promising results of two T-cell-dependent bi-specific antibodies for the treatment of multiple myeloma: one targets FcRH5 expressed on B cells, whereas the other targets the B cell maturation antigen expressed on plasma cells.

AB - In this issue of Cancer Cell, Li et al. and Seckinger et al. describe promising results of two T-cell-dependent bi-specific antibodies for the treatment of multiple myeloma: one targets FcRH5 expressed on B cells, whereas the other targets the B cell maturation antigen expressed on plasma cells.

UR - http://www.scopus.com/inward/record.url?scp=85015062776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015062776&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2017.02.011

DO - 10.1016/j.ccell.2017.02.011

M3 - Short survey

C2 - 28292432

AN - SCOPUS:85015062776

SN - 1535-6108

VL - 31

SP - 305

EP - 307

JO - Cancer cell

JF - Cancer cell

IS - 3

ER -

Antibodies Create Killer Bonds in Myeloma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this